The functional consequences of delivery of HIV-1 Nef to dendritic cells using an adenoviral vector

Vaccine

Volumn 22, Issue 3-4, 2004, Pages 528-535

  Maccormac, Luci P ^a   Jacque, Jean Marc ^b   Chain, Benjamin ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b Program in Molecular Medicine   (United States)

Author keywords

Adenovirus; Dendritic cells; HIV; Nef

Indexed keywords

ADENOVIRUS VECTOR; CD4 ANTIGEN; CD40 ANTIGEN; CD8 ANTIGEN; CD86 ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NEF PROTEIN; TUBERCULIN;

ADULT; ARTICLE; CELL ACTIVITY; CELL STIMULATION; CELL SURFACE; CELLULAR IMMUNITY; CONTROLLED STUDY; DENDRITIC CELL; DRUG DELIVERY SYSTEM; GENE DELIVERY SYSTEM; HEPATITIS B; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOGENICITY; LEUKOCYTE; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; VIRAL GENE DELIVERY SYSTEM; VIRUS PATHOGENESIS; VIRUS STRAIN;

EID: 0345096572     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2003.07.009     Document Type: Article

References (31)

1. Swingler S., Mann A., Jacque J.et al. HIV-1 Nef mediates lymphocyte chemotaxis and activation by infected macrophages. Nat. Med. 5(9):1999;997-1103.
2. Alexopoulou L., Holt A.C., Medzhitov R., Flavell R.A. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature. 413(6857):2001;732-738.
3. Granelli-Piperno A., Delgado E., Finkel V., Paxton W., Steinman R.M. Immature dendritic cells selectively replicate macrophagetropic (M-tropic) human immunodeficiency virus type 1, while mature cells efficiently transmit both M- and T-tropic virus to T cells. J. Virol. 72(4):1998;2733-2737.
4. MacDougall T.H., Shattock R.J., Madsen C., Chain B.M., Katz D.R. Regulation of primary HIV-1 isolate replication in dendritic cells. Clin. Exp. Immunol. 127(1):2002;66-71.
5. Suzuki S., Tobiume M., Kameoka M.et al. Exposure of normal monocyte-derived dendritic cells to human immunodeficiency virus type-1 particles leads to the induction of apoptosis in co-cultured CD4+ as well as CD8+ T cells. Microbiol. Immunol. 44(2):2000;111-121.
6. Alter G., Merchant A., Tsoukas C.M.et al. Human immunodeficiency virus (HIV)-specific effector CD8 T cell activity in patients with primary HIV infection. J. Infect. Dis. 185(6):2002;755-765.
7. Evans D.T., O'Connor D.H., Jing P.et al. Virus-specific cytotoxic T-lymphocyte responses select for amino-acid variation in simian immunodeficiency virus Env and Nef. Nat. Med. 5(11):1999;1270-1276.
8. Gallimore A., Cranage M., Cook N.et al. Early suppression of SIV replication by CD8+ nef-specific cytotoxic T cells in vaccinated macaques. Nat. Med. 1(11):1995;1167-1173.
9. Zhong L., Granelli-Piperno A.et al. Pope M, presentation of SIVgag to monkey T cells using dendritic cells transfected with a recombinant adenovirus. Eur. J. Immunol. 30(11):2000;3281-3290.
10. Chassin D., Andrieu M., Cohen W.et al. Dendritic cells transfected with the nef genes of HIV-1 primary isolates specifically activate cytotoxic T lymphocytes from seropositive subjects. Eur. J. Immunol. 29(1):1999;196-202.
11. Andrieu M., Chassin D., Desoutter J.F.et al. Downregulation of major histocompatibility class I on human dendritic cells by HIV Nef impairs antigen presentation to HIV-specific CD8+ T lymphocytes. AIDS Res. Hum. Retroviruses. 17(14):2001;1365-1370.
12. Sol-Foulon N., Moris A., Nobile C.et al. HIV-1 Nef-induced upregulation of DC-SIGN in dendritic cells promotes lymphocyte clustering and viral spread. Immunity. 16(1):2002;145-155.
13. Verhasselt B., Naessens E., Verhofstede C.et al. Human immunodeficiency virus nef gene expression affects generation and function of human T cells, but not dendritic cells. Blood. 94(8):1999;2809-2818.
14. Cramer L.A., Frelinger J.A. Dendritic cells transduced with HIV Nef express normal levels of HLA-A and HLA-B class I molecules. J. Acquir. Immune. Defic. Syndr. 27(5):2001;417-425.
15. Woodhead V.E., Binks M.H., Chain B.M., Katz D.R. From sentinel to messenger: an extended phenotypic analysis of the monocyte to dendritic cell transition. Immunology. 94(4):1998;552-559.
16. Olive M., Eisenlohr L., Flomenberg N., Hsu S., Flomenberg P. The adenovirus capsid protein hexon contains a highly conserved human CD4+ T-cell epitope. Hum. Gene Ther. 13(10):2002;1167-1178.
17. Ritter T., Lehmann M., Volk H. Improvements in gene therapy: averting the immune response to adenoviral vectors. Bio. Drugs. 16(1):2002;3-10.
18. Messmer D., Jacque J.M., Santisteban C.et al. Endogenously expressed nef uncouples cytokine and chemokine production from membrane phenotypic maturation in dendritic cells. J. Immunol. 169(8):2002;4172-4182.
19. Zhong L., Granelli-Piperno A., Choi Y., Steinman R.M. Recombinant adenovirus is an efficient and non-perturbing genetic vector for human dendritic cells. Eur. J. Immunol. 29(3):1999;964-972.
20. Borgland S.L., Bowen G.P., Wong N.C., Libermann T.A., Muruve D.A. Adenovirus vector-induced expression of the C-X-C chemokine IP-10 is mediated through capsid-dependent activation of NF-kappaB. J. Virol. 74(9):2000;3941- 3947.
21. Miller G., Lahrs S., Pillarisetty V.G., Shah A.B., DeMatteo R.P. Adenovirus infection enhances dendritic cell immunostimulatory properties and induces natural killer and T-cell-mediated tumor protection. Cancer Res. 62(18):2002;5260-5266.
22. Korst R.J., Mahtabifard A., Yamada R., Crystal R.G. Effect of adenovirus gene transfer vectors on the immunologic functions of mouse dendritic cells. Mol. Ther. 5(3):2002;307-315.
23. Lyakh L.A., Koski G.K., Young H.A., Spence S.E., Cohen P.A., Rice N.R. Adenovirus type 5 vectors induce dendritic cell differentiation in human CD14(+) monocytes cultured under serum-free conditions. Blood. 99(2):2002;600-608.
24. Schnell M.A., Zhang Y., Tazelaar J.et al. Activation of innate immunity in nonhuman primates following intraportal administration of adenoviral vectors. Mol. Ther. 3(5 Pt 1):2001;708-722.
25. Morelli A.E., Larregina A.T., Ganster R.W.et al. Recombinant adenovirus induces maturation of dendritic cells via an NF-kappaB-dependent pathway. J. Virol. 74(20):2000;9617-9628.
26. Rea D., Schagen F.H., Hoeben R.C.et al. Adenoviruses activate human dendritic cells without polarization toward a T-helper type 1-inducing subset. J. Virol. 73(12):1999;10245-10253.
27. Flomenberg P., Piaskowski V., Truitt R.L., Casper J.T. Characterization of human proliferative T cell responses to adenovirus. J. Infect. Dis. 171(5):1995;1090-1096.
28. Olive M., Eisenlohr L.C., Flomenberg P. Quantitative analysis of adenovirus-specific CD4+ T-cell responses from healthy adults. Viral Immunol. 14(4):2001;403-413.
29. Jenne L., Hauser C., Arrighi J.F., Saurat J.H., Hugin A.W. Poxvirus as a vector to transduce human dendritic cells for immunotherapy: abortive infection but reduced APC function. Gene Ther. 7(18):2000;1575-1583.
30. Fujii Y., Otake K., Fujita Y.et al. Clustered localization of oligomeric Nef protein of human immunodeficiency virus type 1 on the cell surface. FEBS Lett. 395(2-3):1996;257-261.
31. Cocchi F., DeVico A.L., Garzino-Demo A., Arya S.K., Gallo R.C., Lusso P. Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. Science. 270(5243):1995;1811- 1815.